Report Overview
This report provides a deep insight into the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market in any manner.
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Minhai Bio
Kexing Bio
Cansino Bio
Lanzhou Biological Preparations Institute
Market Segmentation (by Type)
Serotype 6B
7F Serotype
Serotype 9V
14 Serotype
Serotype 18C
Serotype 19A
19F Serotype
23F Serotype
24F Serotype
Other
by Application
Market Segmentation (by Application)
Infants from 6 Weeks to 15 Months Old
Children Aged 15 Months to 5 Years
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market
? Overview of the regional outlook of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
1.2 Key Market Segments
1.2.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Type
1.2.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Overview
2.1 Global Market Overview
2.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Competitive Landscape
3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Manufacturers (2019-2024)
3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Manufacturers (2019-2024)
3.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Sites, Area Served, Product Type
3.6 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Competitive Situation and Trends
3.6.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Concentration Rate
3.6.2 Global 5 and 10 Largest 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Chain Analysis
4.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2019-2024)
6.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Market Share by Type (2019-2024)
6.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Type (2019-2024)
7 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Sales by Application (2019-2024)
7.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size (M USD) by Application (2019-2024)
7.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate by Application (2019-2024)
8 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Segmentation by Region
8.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
8.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
8.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region
8.2 North America
8.2.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Basic Information
9.1.2 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Overview
9.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Minhai Bio
9.2.1 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Basic Information
9.2.2 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Overview
9.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Market Performance
9.2.4 Minhai Bio Business Overview
9.2.5 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) SWOT Analysis
9.2.6 Minhai Bio Recent Developments
9.3 Kexing Bio
9.3.1 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Basic Information
9.3.2 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Overview
9.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Market Performance
9.3.4 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) SWOT Analysis
9.3.5 Kexing Bio Business Overview
9.3.6 Kexing Bio Recent Developments
9.4 Cansino Bio
9.4.1 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Basic Information
9.4.2 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Overview
9.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Market Performance
9.4.4 Cansino Bio Business Overview
9.4.5 Cansino Bio Recent Developments
9.5 Lanzhou Biological Preparations Institute
9.5.1 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Basic Information
9.5.2 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Overview
9.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Market Performance
9.5.4 Lanzhou Biological Preparations Institute Business Overview
9.5.5 Lanzhou Biological Preparations Institute Recent Developments
10 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast by Region
10.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast
10.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Country
10.2.3 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Region
10.2.4 South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2025-2030)
11.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2025-2030)
11.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast by Application (2025-2030)
11.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons) Forecast by Application
11.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Comparison by Region (M USD)
Table 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) as of 2022)
Table 10. Global Market 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Sites and Area Served
Table 12. Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Type
Table 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Challenges
Table 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (Kilotons)
Table 23. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Type (M USD)
Table 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons) by Type (2019-2024)
Table 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2019-2024)
Table 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size (M USD) by Type (2019-2024)
Table 27. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Share by Type (2019-2024)
Table 28. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (USD/Ton) by Type (2019-2024)
Table 29. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons) by Application
Table 30. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Application
Table 31. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2019-2024)
Table 33. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2019-2024) & (M USD)
Table 34. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Application (2019-2024)
Table 35. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate by Application (2019-2024)
Table 36. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2019-2024)
Table 38. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Basic Information
Table 44. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Overview
Table 45. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Basic Information
Table 50. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Overview
Table 51. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Minhai Bio Business Overview
Table 53. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) SWOT Analysis
Table 54. Minhai Bio Recent Developments
Table 55. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Basic Information
Table 56. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Overview
Table 57. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) SWOT Analysis
Table 59. Kexing Bio Business Overview
Table 60. Kexing Bio Recent Developments
Table 61. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Basic Information
Table 62. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Overview
Table 63. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Cansino Bio Business Overview
Table 65. Cansino Bio Recent Developments
Table 66. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Basic Information
Table 67. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Overview
Table 68. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Lanzhou Biological Preparations Institute Business Overview
Table 70. Lanzhou Biological Preparations Institute Recent Developments
Table 71. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size (M USD), 2019-2030
Figure 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size (M USD) (2019-2030)
Figure 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Country (M USD)
Figure 11. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Manufacturers in 2023
Figure 12. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Manufacturers in 2023
Figure 13. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Type
Figure 18. Sales Market Share of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2019-2024)
Figure 19. Sales Market Share of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type in 2023
Figure 20. Market Size Share of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2019-2024)
Figure 21. Market Size Market Share of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Application
Figure 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2019-2024)
Figure 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application in 2023
Figure 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Application (2019-2024)
Figure 27. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Application in 2023
Figure 28. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate by Application (2019-2024)
Figure 29. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2019-2024)
Figure 30. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2023
Figure 32. U.S. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2023
Figure 37. Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region in 2023
Figure 44. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (Kilotons)
Figure 50. South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2023
Figure 51. Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share Forecast by Type (2025-2030)
Figure 65. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Application (2025-2030)
Figure 66. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share Forecast by Application (2025-2030)
